Talk:Tedizolid
Appearance
This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||
|
Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Tedizolid.
|
What results of the completed phase III trial
[edit]Did it meet primary endpoint ? - Rod57 (talk) 09:20, 29 December 2012 (UTC)
http://www.ncbi.nlm.nih.gov/pubmed/24909499 — Preceding unsigned comment added by 198.49.6.225 (talk) 10:28, 16 June 2015 (UTC)
FDA priority review may give extra 5 years exclusivity
[edit]Trius gets boost for 'superbug' antibiotic - could mention. - Rod57 (talk) 19:50, 30 January 2013 (UTC)
Inconsistent page
[edit]Chembox data refers to the unphosphate form of the molecule (PubMed CID 11476460), while text refers to the phosphate one (PubMed CID 11234049). Manfre87 (talk) 13:13, 28 August 2015 (UTC)